[1] BioReperia AB,Pathology Department
[2] Athens Chest Hospital “Sotiria”,3rd Department of Internal Medicine and Laboratory
[3] National & Kapodistrian University of Athens,Program Against Cancer Therapeutic Resistance (ProCURE)
[4] InCELLiA P.C,Division of Cardiovascular Medicine, Department of Medical and Health Sciences
[5] Catalan Institute of Oncology (ICO),Division of Cell Biology, Department of Biomedical and Clinical Sciences
[6] Bellvitge Institute for Biomedical Research (IDIBELL),undefined
[7] Oncobell Program,undefined
[8] L’Hospitalet del Llobregat,undefined
[9] Xenopat S.L.,undefined
[10] Parc Cientific de Barcelona (PCB),undefined
[11] XenoSTART,undefined
[12] Linköping University,undefined
[13] Charles River Laboratories,undefined
[14] Linköping University,undefined